(Q33340852)

English

Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer (English)

1 reference

Europe PubMed Central

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Giuseppe Curigliano

object named as

G Curigliano

5

0 references

author name string

S Fogli

1

1 reference

Europe PubMed Central

25 July 2017

R Danesi

2

1 reference

Europe PubMed Central

25 July 2017

F De Braud

3

1 reference

Europe PubMed Central

25 July 2017

T De Pas

4

1 reference

Europe PubMed Central

25 July 2017

G Giovannetti

6

1 reference

Europe PubMed Central

25 July 2017

M Del Tacca

7

1 reference

Europe PubMed Central

25 July 2017

publication date

1 November 2001

1 reference

Europe PubMed Central

25 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

25 July 2017

12

1 reference

Europe PubMed Central

25 July 2017

11

1 reference

Europe PubMed Central

25 July 2017

1553-1559

1 reference

Europe PubMed Central

25 July 2017

The taxoids. Comparative clinical pharmacology and therapeutic potential

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Schedule dependent toxicity and efficacy of combined gemcitabine/paclitaxel treatment in mouse adenocarcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacokinetics of a 1-h paclitaxel infusion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrotubule agents induce polyploidization of human leukaemic cell lines with megakaryocytic features.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013133415945

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1013133415945

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33340852&oldid=2143944010"